生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Saquinavir is an orally active and selective HIV proteinase inhibitor. It was highly active against HIV in human cells that are acutely or chronically infected with the virus in in vitro study. Saquinavir had IC50 and IC90 values ranged from 1-30nM and 5-80nM, respectively. Recent study found that Saquinavir showed inhibition effect on 2019-nCoV. | ||
作用机制 | Saquinavir is a peptide-like substrate analogue that inhibits HIV protease, which is required for the cleavage of viral polyprotein precursor into individual functional proteins as found in infectious HIV, by binding to its active site. Inhibition of HIV protease leads to the production of immature non-infectious virus particles. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01936870 | - | Completed | - | - | |
NCT01936870 | - | Completed | - | - | |
NCT02556268 | HIV-DDI | Phase 1 | Completed | - | United States, Florida ... 展开 >> Orlando, Florida, United States, 32803 United States, Massachusetts Boston, Massachusetts, United States, 02118 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.49mL 0.30mL 0.15mL |
7.45mL 1.49mL 0.75mL |
14.91mL 2.98mL 1.49mL |
参考文献 |
---|